Although the identification of conolidine as a possible novel analgesic agent presents an additional avenue to deal with the opioid crisis and manage CNCP, more scientific tests are required to be familiar with its mechanism of action and utility and efficacy in controlling CNCP. No healthcare promises are implied https://franciszekq582mve6.blogproducer.com/profile